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1. Introduction
Gastric cancer (GC) is one of the unresolved causes of 
cancer mortality worldwide with a high rate of incidence 
and death (1,2). It is the second and fourth most common 
cancer leading to a high death rate in men and women, 
respectively (3,4). Lack of reliable diagnostic methods 
in early stages of GC denies the majority of patients an 
effective treatment (3,5). Accordingly, to overcome these 
problems, it is critical to find novel biomarkers to improve 
the chance to diagnose GC in its early stages.
As a novel type of endogenous noncoding RNAs, 
circular RNAs (circRNAs) are formed by a covalent link 
between 5’ and 3’ ends (6–8). They are very stable and 
abundant in eukaryotes (9–11). Recent reports show 
that circRNAs can function as microRNA sponges, 
regulate gene expression, linear RNA transcription and 
protein production (7). Association between circRNAs 
and several diseases like atherosclerotic vascular disease 
(12), Alzheimer (13), and various cancer types (14) has 
been documented and could represent these molecules as 
attractive novel biomarkers.
cir-ITCH is a circular RNA which is derived from 
Itchy E3 ubiquitin protein ligase (ITCH) gene (10,15). 
Deregulation of cir-ITCH has been recently reported 
in esophageal squamous cell carcinoma (ESCC) (16), 
colorectal cancer (17), and lung cancer. Further functional 
studies showed that cir-ITCH can act as microRNA sponge 
thus increasing the level of parental gene, ITCH (15). 
In 2016, by characterizing circRNA, transcripts using 
RNA-sequencing (RNA-seq) from six normal tissues 
(brain, colon, heart, liver, lung, and stomach) and seven 
cancerous tissues including gastric cancer, Zheng et al. 
introduced an abundant circRNA derived from Exon2 
of the HIPK3 gene, termed circHIPK3. Their functional 
assays revealed that circHIPK3 may function to modulate 
the growth of human cells (18). 
As there were no reported studies on the expression 
profiles of these two circular RNAs in gastric cancer, in 
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the current study, we aimed to delineate the expression 
profiles of cir-ITCH and circHIPK3 in gastric cancer tissues 
compared to their paired adjacent noncancerous tissues. 
Then, the clinicopathological relevance of these two 
circular RNAs with gastric cancer was further examined.
2. Materials and methods
2.1. Clinical specimens
A total of 30 pairs of gastric cancer and matched adjacent 
nontumoral tissues were obtained from patients with 
gastric cancer. The specimens were collected by the Iran 
National Tumor Bank, which is funded by the Cancer 
Institute of Tehran University, for Cancer Research (19–
21). There, the tissues are immediately snap-frozen in 
the liquid nitrogen. Informed written consent was taken 
from the patients by Iran National Tumor Bank. The study 
protocol was approved by the Ethics Committee of Isfahan 
University of Medical Sciences and was in accordance with 
the Helsinki Declaration. The clinical staging of the tumor 
samples was based on the seventh edition of the American 
Joint Committee on Cancer classification (AJCC) cancer 
staging manual for stomach (22).
2.2. Total RNA extraction and complementary DNA 
(cDNA) synthesis
TRIzol® reagent (Invitrogen, California, USA) was used to 
extract total RNA from powdered gastric cancer tissues, 
following the manufacturer’s instructions. One percent 
agarose gel electrophoresis was used to assess the quality 
of the RNA. Purity and quantity of the total RNA were 
determined with Nanodrop instrument (Nanolytik, 
Düsseldorf, Germany). DNase treatment was performed 
by using DNase set (Fermentas, Vilnius, Lithuania) for 
eliminating genomic DNA. cDNA was synthesized by 
using PrimeScriptTM RT reagent Kit (TaKaRa, Kusatsu, 
Shiga, Japan) according to manufacturer’s protocol.
2.3. Quantitative real-time PCR and DNA sequencing
Applying the relative quantitative real-time RT-PCR, 
the expression levels of cir_ITCH and circHIPK3 were 
assessed compared to GUSB (β-Glucuronidase) as an 
internal control (23). Divergent primers, rather than 
convergent primers, were designed with GeneRunner 
software, version 4.0 to amplify the circular RNAs. Basic 
local alignment search tool (BLAST) (http://blast.ncbi.
nlm.nih.gov/Blast.cgi) was used for confirmation of unity 
attachment of divergent primers to genome. A set of 
convergent primers in an opposite direction were designed 
to amplify only the linear forms. The sequences of primers 
are listed in Table 1. RealQ Plus 2x Master Mix, green (high 
ROX) (AMPLIQON, Odense M, Denmark) was applied in 
an Applied Biosystems StepOnePlus™ instrument for PCR 
amplification. The amplification conditions consisted of 
an initial denaturation at 95 °C for 2 min, then 30 cycles 
of denaturation at 95 °C for 30 s, annealing at 55.9 °C for 
cir_ITCH and circHIPK3 and at 60 °C for GUSB genes for 
60 s, and the extension step for 30 s at 72 °C. Furthermore, 
the PCR products of some samples were sequenced with 
an Applied Biosystems 3730XL sequencer (Macrogen, 
Seoul, South Korea) to verify the specific amplification of 
circular RNAs.
2.4. Statistical gene expression analysis
The ΔCt method was applied to relatively quantify the 
levels of gene expressions. All experiments were performed 
at least three times and expressed as means ± standard 
error of mean (SEM). To check the normal distribution of 
samples, Kolmogorov–Smirnov test was applied. Student’s 
t-test, analysis of variance (ANOVA), and chi-square 
tests were performed to examine statistical significances. 
Data were analyzed by SPSS software, version 16.0 (SPSS, 
Chicago, IL, USA) and P-values less than 0.05 were 
considered statistically significant.
3. Results
3.1. PCR optimization of the cir_ITCH and circHIPK3
We designed two sets of primer pairs: a divergent primer 
set for only amplification of the circular form and a 
convergent one to amplify the linear form. We utilized 
Table1.The sequences of primers used in the current study.
Name Sequence (5’--> 3’) Ta for PCR (°C) Amplicon size
Divergent
primers
hcircITCH-F1 GTCCGGAACTATGAACAATG
55.9 207 bp
hcircITCH-R1 CTCTGTTGGCTCTTTGTCAC
hcircHIPK3-F1 TATGTTGGTGGATCCTGTTC
55.9 213 bp
hcirc HIPK3-R1 AACTGCTTGGCTCTACTTTG
Convergent 
primers
hlinITCH-F1 GGTTCACCATCTGCCACTTC
60.7 169 bp
hlinITCH-R1 AGGGAGCTTGAGTTACAGGATT
hlin HIPK3-F1 GAAAGAAACTATCCACGGAC
54.4 177 bp
hlin HIPK3-R1 TATGACCTTTGTAGCACCTG
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the cDNA and DNA of a human lung adenocarcinoma 
epithelial cell line (A540) for PCR optimization. As 
expected, no amplification was seen with divergent primers 
on DNA template, whereas we could detect the expected 
bands corresponding to circular forms of RNAs (Figure 1). 
Products giving a band were sequenced by conventional 
Sanger capillary methods and compared to the reference 
sequence. Sanger sequencing of the RT-PCR products of 
cir_ITCH and circHIPK3 showed that convergent primers 
could specifically amplify the circular forms of RNAs (data 
not shown).
3.2. cir_ITCH and circHIPK3 expression levels were sig-
nificantly downregulated in GC tumoral tissues and were 
significantly correlated with various clinicopathological 
parameters
The results of real-time qRT-PCR experiments showed 
that expression of both cir_ITCH and circHIPK3 were 
significantly downregulated (P = 0.015 and P = 0.046, 
respectively) in GC tumoral tissues compared with their 
paired adjacent nontumoral tissues (Figure 2). Analyzing 
melting curves showed single peaks with neither primer 
dimers nor nonspecific amplification, further confirming 
the specificity of cir_ITCH and circHIPK3 amplifications.
Further analyses showed that circHIPK3 expression 
was related with numerous clinicopathological features of 
tumoral tissues. As shown in Table 2, circHIPK3 expression 
level was significantly associated with age (P = 0.002) and M 
classification (P = 0.045). GC patients were further classified 
into two groups based on the median value of circHIPK3 
expression in tumoral tissues. circHIPK3 expression levels 
stratified based on median value showed a significant 
association with age (P = 0.01) (Table 3). Same analyses 
on cir_ITCH showed a significant correlation between 
circRNA expression levels and age (P = 0.0005) and tumor 
grades (P = 0.02) (Tables 4 and 5). We furthermore tested 
Figure 1. Identification of circHIPK3 and cir_ITCH in a human 
lung adenocarcinoma epithelial cell line (A540). A) RT-PCR 
products with divergent and convergent primers of circHIPK3 
verified that specificity of designed primers. B) Specific divergent 
primers of cir_ITCH could amplify a 207 bp PCR product using a 
cDNA as a PCR template but not a genomic DNA (gDNA).
Figure 2. Relative expression of circHIPK3 and cir_ITCH in 
tumoral and nontumoral gastric tissue samples. A higher ΔCt 
value shows higher relative expression levels. Error bars stand for 
standard error of mean (SEM). A) circHIPK3, B) cir_ITCH.
690
GHASEM et al. / Turk J Med Sci
if there is any correlation between gene expression levels 
and the anatomical location of tumors within the stomach. 
Although the stomach is anatomically divided into four 
regions, i.e. the cardia, fundus, body, and pylorus, the two 
main regions in our patient cohort were the cardia and the 
main body. Therefore, we compared the gene expressions 
between these two groups (body vs. cardia) and found no 
statistically significant difference in gene expressions of the 
two examined circular RNAs between tumors in the main 
body of the stomach and the ones in cardia (1.06 ± 1.03 vs. 
−1.54 ± 1.67 for cir_ITCH (P = 0.20) and 1.14 ± 0.62 vs. 
−0.57 ± 1.18 for circHIPK3 (P = 0.22)).
Table 2. The relationship between circHIPK3 expression level (based on mean ± SEM gene 
expression level) in GC tissues with clinicopathological parameters.
Characteristics Numbers(#30)(%)
circHIPK3
(mean ± SEM*) P-value
Gender 
      Male
      Female
17(56.67)
13(44.33)
0.29 ± 0.66
0.37 ± 0.46
0.25
Age (years) 
      ≥70 
      <70
15(50.00)
15(50.00)
1.93 ± 0.44
−1.28 ± 0.55
0.002**
Depth of invasion
      T2 
      T3-T4
1(3.33.00)
29(96.67)
−3.21 ± 
0.45 ± 0.57
0.14
N classification 
      NX-N0 
      N1
      N2-N3
6(20.00)
11(36.67)
13(43.33)
−1.01 ± 0.81
1.52 ± 0.44
−0.07 ± 0.53
0.16
M classification 
      MX 
      M0 
      M1
5(16.67)
19(63.33)
6(20.00)
−0.47  ± 0.23
1.31 ± 0.54
−1.89 ± 0.66
0.045**
(M0 vs. M1)
TNM stage 
      I-II
      III
      IV
16(53.33)
8(26.67)
6(20.00)
0.86 ± 0.56
0.92 ± 0.44
−1.89 ± 0.66
0.16
Perineural invasion 
      Negative 
      Positive
12(40.00)
18(60.00)
0.08  ± 0.66
0.57 ± 0.51
0.28
Lymphatic invasion 
      Negative 
      Positive
6(20.00)
24(80.00)
0.91 ± 0.53
0.24 ± 0.46
0.20
Tumor size (cm) 
       ≥5 
       <5
25(83.33)
5(16.67)
0.23  ± 0.57
0.79 ± 0.64
0.40
Tumor grades 
       I 
       II 
       III
9(30.00)
8(26.67)
13(43.33)
−0.84 ± 0.67
0.98 ± 0.61
0.73 ± 0.48
0.25
Tumor types 
       Diffuse 
       Intestinal
14(46.67)
16(53.33)
0.78 ± 0.49
−0.07 ± 0.64
0.38
* A higher ΔCt value indicates higher expression.
** Statistically significant.
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4. Discussion
In the current study, we explored the expression levels 
of circHIPK3 and cir_ITCH in gastric cancer tissues 
compared to their paired adjacent noncancerous tissues as 
well as their clinicopathological significance.
Our results showed a significant underexpression of 
circHIPK3 in GC tumoral tissues. Using RNA sequencing 
(RNA-seq), Zheng et al. (18) characterized an abundant 
circular RNA derived from the HIPK3 gene, termed 
circHIPK3. They reported the significant overexpression 
Table 3. The relationship between circHIPK3 expression level (as divided into two groups based on the median of 
ΔCt) in GC tissues with clinicopathological parameters
Characteristic Number (#30) circHIPK3 expression P-value
Low (#15) High (#15)
Gender
       Male
       Female
17
13
9
6
8
7
0.50
Age (years) 
       ≥70 
       <70
15
15
4
11
11
4
0.01**
Depth of invasion
       T2 
       T3-T4
1
29
1
14
-
15
0.50
N classification 
       NX-N0 
       N1
       N2-N3
6
11
13
3
4
8
3
7
5
0.23
M classification 
       MX 
       M0 
       M1
5
19
6
4
7
4
1
12
2
0.09
(M0 vs. M1)
TNM stage 
       I-II 
       III
       IV
16
8
6
7
4
4
9
4
2
0.31
Perineural invasion 
       Negative 
       Positive
12
18
6
9
6
9
0.50
Lymphatic invasion 
       Negative 
       Positive
6
24
2
13
4
11
0.32
Tumor size (cm) 
       ≥5 
       <5
25
5
12
3
13
2
0.50
Tumor grades 
       I 
       II 
       III
9
8
13
6
4
5
3
4
8
0.21
Tumor types 
       Diffuse 
       Intestinal
14
16
6
9
8
7
0.35
* A higher ΔCt value indicates higher expression.
** Statistically significant.
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of circHIPK3 in liver cancer compared with their matched 
normal tissues. In 2017, Li et al. (24) measured the relative 
expression of circHIPK3 in 44 pairs of bladder cancer and 
normal bladder tissues. Consistent with their RNA-seq 
results, they observed a significant decrease of circHIPK3 
levels in 79.5% of bladder tumoral tissues compared to 
their normal counterparts. Overexpression of circHIPK3 
in bladder cancer cell lines could suppress migration, 
invasion, and angiogenesis in vitro and inhibit bladder 
cancer growth and metastasis in vivo. Their findings 
support the tumor-suppressive activity of circHIPK3 in 
bladder cancer. In agreement with the results of expression 
Table 4. The relationship between cir_ITCH expression level (based on mean ± SEM gene expression level) in 
GC tissues with clinicopathological parameters
Characteristics Numbers (#30)(%) cir_ITCH (mean±SEM*) P-value
Gender 
      Male
      Female
16(53.33)
14(46.66)
0.31 ± 0.93
0.23 ± 0.75
0.42
Age (years) 
      ≥70 
      <70
14(46.66)
16(53.33)
2.66 ± 0.76
−2.11 ± 0.69
0.0005**
Depth of invasion
      T2 
      T3-T4
1(3.33)
29(96.67)
0.45 ± 
0.27 ± 0.85
0.50
N classification 
      NX-N0 
      N1
      N2-N3
6(20.00)
11(36.67)
13(43.33)
−1.18 ± 1.25
0.89 ± 0.87
0.42 ± 0.61
0.45
M classification 
      MX 
      M0 
      M1
5(16.67)
19(63.33)
6(20.00)
−2.24 ± 0.33
1.76 ± 0.63
−1.62 ± 1.34
0.16
(M0 vs. M1)
TNM stage 
      I-II
      III
      IV
16(53.33)
8(26.67)
6(20.00)
1.19 ± 0.68
0.41 ± 0.60
−2.35 ± 1.35
0.23
Perineural invasion 
      Negative 
      Positive
12(40.00)
18(60.00)
−0.34 ± 0.96
0.68 ± 0.77 0.44
Lymphatic invasion 
      Negative 
      Positive
6(20.00)
24(80.00)
3.28 ± 1.60
−0.04 ± 0.89
0.08
Tumor size (cm) 
       ≥5 
      <5
25(83.33)
5(16.67)
−0.02 ± 0.89
1.72 ± 0.49
0.19
Tumor grades 
       I 
       II 
       III
9(30.00)
8(26.67)
13(43.33)
−2.36 ± 0.84
−0.77 ± 0.61
2.74 ± 0.77
0.02**
Tumor types 
       Diffuse 
       Intestinal
14(46.66)
16(46.66)
1.68 ± 0.82
−0.96 ± 0.82
0.06
* A higher ΔCt value indicates higher expression.
** Statistically significant.
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of this circular RNA in bladder cancer (24), we also 
observed the relative downregulation of circHIPK3 in 
gastric cancer tumoral tissues. The discrepancy between Li 
et al. (24) and our results vs. findings of Zheng et al. (18) 
on liver cancer may be ascribed to the potential tissue-
specific expression and function of circHIPK3.
We furthermore analyzed the relative expression 
of cir_ITCH in GC and found that it was significantly 
underexpressed in tumoral tissues compared to the 
nontumoral adjacent tissues. The association between 
cir_ITCH and cancer was firstly described in a study 
on esophageal squamous cell carcinoma conducted by 
Table 5. The relationship between cir_ITCH expression level (as divided into two groups based on the median of 
ΔCt) in GC tissues with clinicopathological parameters.
Characteristic Number (#30)(%) cir_ITCH expression P-value
Low (#15) High (#15)
Gender 
       Male
       Female
16
14
7
8
9
6
0.36
Age (years) 
       ≥70 
       <70
14
16
2
13
12
3
0.0005**
Depth of invasion
       T2 
       T3-T4
1
29
1
14
0
15
0.50
N classification 
       NX-N0 
       N1
       N2-N3
6
11
13
5
5
5
1
6
8
0.08
M classification 
       MX 
       M0 
       M1
5
19
6
5
7
3
0
12
3
0.28
(M0 vs. M1)
TNM stage 
       I-II 
       III
       IV
16
8
6
7
4
4
9
4
2
0.31
Perineural invasion 
       Negative  
       Positive
12
18
5
10
7
8
0.35
Lymphatic invasion 
       Negative 
       Positive
6
24
2
13
4
11
0.34
Tumor size (cm) 
       ≥5 
       <5
25
5
12
3
13
2
0.50
Tumor grades 
       I 
       II 
       III
9
8
13
7
4
4
2
4
9
0.04**
Tumor types 
       Diffuse 
       Intestinal
14
16
5
10
9
6
0.13
* A higher ΔCt value indicates higher expression.
** Statistically significant.
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Li et al. (16). cir_ITCH was highly and significantly 
expressed in around 70.61% of tumoral tissues compared 
to their paired nontumoral tissues (16). Evaluation of 
cir_ITCH expression in colorectal cancer (17) showed its 
underexpression in 75.6% of cancerous tissues compared 
with the adjacent noncancerous tissues. In 2016, Wan et 
al. (15) evaluated the expression levels of cir_ITCH in a 
cohort of lung cancer compared to their paired adjacent 
normal tissues. Compared to non-tumoral lung tissues, 
cir_ITCH showed a significantly lower expression in 
73.08% of tumoral tissues (15). Taken together, our result 
on gastric cancer is consistent with those of previous 
reports on ESCC (16), colorectal cancer (17), and lung 
cancer (15).
In 2017, Li et al. (24) reported a negative correlation 
of circHIPK3 expression levels with bladder cancer grade, 
invasion, stage and the lymph nodes metastasis. In the same 
vein, we also observed that those patients with metastasis 
had a significant lower expression levels for this circular 
RNA. Gastric cancer patients with higher TNM stage or 
positive lymphatic invasion had lower levels of circHIPK3, 
although these correlations were not significant.
Furthermore, we found that the cir_ITCH expression 
level was significantly associated with age, metastasis, and 
cancer grades. Consistently, Wan et al. (15) reported a 
significant association between age and expression levels 
of this circular RNA in a cohort of lung cancer tissues.
5. Conclusions
In summary, our results showed that the expression of cir_
ITCH and circHIPK3 were significantly down regulated in 
GC tumoral tissues compared with their paired adjacent 
non-neoplastic counterparts. Further investigation of 
these preliminary results is needed to elucidate the precise 
functional roles of these two circular RNAs in gastric 
cancer pathogenesis. cir_ITCH and circHIPK3 may serve 
in future as potential prognostic biomarkers in cancer.
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